Press release
Dermatophytic Onychomycosis Therapeutics Market will surge to a market valuation of US$ 10.30 Bn by the end of 2031 | North America, Europe, APAC Region
Dermatophytic Onychomycosis Therapeutics Market
Additionally, the infection may spread to nearby skin. Although the illness is not thought to be life-threatening, it may pose physical and occupational constraints, which is why an increasing number of people are choosing to have their infected, thick, and cracked nails treated. The market for treatments for dermatophytic onychomycosis is consequently expanding.
Request for Free Sample Copy of Dermatophytic Onychomycosis Therapeutics Market @https://www.persistencemarketresearch.com/samples/5840
Tablets and nail paints, which are further divided into prescription (Rx) and over-the-counter, make up the tablet and nail paint segments of the global market for treatments for dermatophytic onychomycosis. The market for treatments for dermatophytic onychomycosis is anticipated to grow at a CAGR of 8.1% over the course of the forecast period, with the nail paint category projected to provide the largest share.
The global market for dermatophytic onychomycosis therapies has been divided into topical and oral treatment segments based on mode of administration. By 2026, the topical sector is expected to hold a about 70% share of the global market for treatments for dermatophytic onychomycosis, making it the dominating segment throughout the forecast period.
Increase in nail infection diagnoses has increased public knowledge of nail fungus infections and treatments for dermatophytic onychomycosis. In addition, dermatophytic onychomycosis therapies are becoming more widely known among podiatrists and dermatologists, which has increased demand for efficient drugs. However, side effects like headache, nausea, dizziness, and stomach discomfort linked to antifungal medications have made patients less confident about using a systemic therapy for nails.
Additionally, the topical medications also make the skin around the affected area rashy and itchy. The acceptability of dermatophytic onychomycosis treatments for the treatment of mild to severe dermatophytic onychomycosis linked with anti-fungal therapeutics is being hampered by these side effects.
Key Players in the Industry -
• Bausch Health
• Galderma S.A.
• Novartis AG
• Pfizer, Inc.
• Moberg Pharma AB
• Bayer AG
• Dr. Reddy's Laboratories Ltd.
• Cipla Ltd.
• Medimetriks Pharmaceuticals, Inc.
• Sanofi S.A.
• GlaxoSmithKline Plc.
• Teva Pharmaceutical industries Ltd.
• Cardinal Health Inc.
• Viatris Inc.
• Almirall, S.A
Request for report Customization@ https://www.persistencemarketresearch.com/request-customization/5840
Geographically, the market for therapies for dermatophytic onychomycosis is divided into five main areas: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa (MEA).
Dermatophytic onychomycosis treatments were primarily sold in North America, and this tendency is anticipated to continue over the projected period. Therapeutics for dermatophytic onychomycosis are predicted to see the second-largest market share in Europe, after Asia Pacific.
Over the course of the forecast period, North America and Europe are anticipated to hold over 60% of the global market for treatments for dermatophytic onychomycosis.
Buy Now this Report @https://www.persistencemarketresearch.com/checkout/5840
Persistence market research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dermatophytic Onychomycosis Therapeutics Market will surge to a market valuation of US$ 10.30 Bn by the end of 2031 | North America, Europe, APAC Region here
News-ID: 2805334 • Views: …
More Releases from Persistence Market Research
Libya Baby Diapers and Wipes Market Set to Reach US$ 392.2 Mn by 2033 Says Persi …
The Libya baby diapers and wipes market is projected to expand at a 4.5% compound annual growth rate (CAGR) from 2023 to 2033, reaching an estimated value of US$ 392.2 million by 2033. The market was valued at US$ 242.9 million at the end of 2022.
Request a Sample: https://www.persistencemarketresearch.com/samples/33030
Key Market Drivers
Several factors are underpinning the growth in the Libyan market for baby diapers and wipes:
• Growing awareness of infant hygiene: As…
Foodservice Packaging Market Worth 522.4 Billion by 2032 - Persistence Market Re …
The foodservice packaging market is undergoing significant transformation, driven by evolving consumer preferences, technological innovations, and rising sustainability demands. Foodservice packaging encompasses a wide range of products including containers, trays, cups, lids, bags, and cutlery used across quick-service restaurants, full-service dining, catering, and delivery platforms.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/22354
As global food consumption habits shift toward convenience and on-the-go…
BOPP for Labels Market to Reach US$ 31.2 Billion by 2032 with 6.1% CAGR, Reports …
The packaging and labelling industry has witnessed significant transformation over the past decade, with brands increasingly seeking materials that are cost-effective, durable, and visually appealing. One material that has gained substantial traction in this context is biaxially oriented polypropylene, commonly known as BOPP. BOPP films are widely recognized for their versatility, excellent printability, and resilience against moisture and chemicals. These characteristics make BOPP an ideal choice for labels across various…
Emulsion Explosives Market to Grow from US$ 2.57 Billion in 2024 to US$ 3.57 Bil …
The global emulsion explosive market has witnessed substantial growth over the past few years, driven by increasing demand from the mining, construction, and infrastructure sectors. Emulsion explosives are considered a safer, more efficient alternative to traditional blasting agents due to their improved performance, water resistance, and enhanced safety profile. Their adoption is growing steadily as industries seek higher productivity, better control, and environmentally safer solutions for blasting operations.
Get a Sample…
More Releases for Dermatophytic
Call for Automation to Drive the Dermatophytic Onychomycosis Therapeutics Market
Advancements in medicine, diagnosis of varieties of illnesses, and increasing elder population at an unprecedented rate have resulted in high demand for novel drugs and therapies for dermatophytic onychomycosis treatment. In 2021, the dermatophytic onychomycosis therapeutics market was valued at nearly US$ 5.5 Bn, and is set to experience a 6.5% CAGR over the forecast period (2022-2031).
Presence and availability of a large clinical pipeline with reference to therapeutic approaches based…
Dermatophytic Onychomycosis Therapeutics (DOT) Market 2022 | Detailed Report
The research reports on “Dermatophytic Onychomycosis Therapeutics (DOT) Market” report gives detailed overview of factors that affect global business scope. Dermatophytic Onychomycosis Therapeutics (DOT) Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample…
Dermatophytic Onychomycosis Therapeutics (DOT) Market
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin…
Dermatophytic Onychomycosis Market Expected to Witness a Sustainable Growth
According to a new report published by Allied Market Research, titled, " Dermatophytic Onychomycosis Market by Product (Nail Paint and Tablet), Route of Administration (Topical and Oral Therapy), and End User (Hospitals, Dermatology & Podiatry Clinics, Independent Pharmacies, Mail Order Pharmacies, and Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2020-2027".
The global market size of Dermatophytic Onychomycosis market is $XX million in 2019 with XX CAGR, and it is…
Dermatophytic Onychomycosis Market Poised to Rake US$ 4,706.3 Mn by 2021
Key players of the global dermatophytic onychomycosis therapeutics market include Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.
Persistence Market Research (PMR) delivers key insights on the global dermatophytic onychomycosis therapeutics Market in its latest report titled “Global Market Study on Dermatophytic…
Dermatophytic Onychomycosis Market : Topical segment to account 70% share
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the…
